Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Rituximab para el tratamiento de los inhibidores en pacientes con hemofilia grave hereditaria

Esta versión no es la más reciente

ver la versión actual 03 agosto 2020

Información

DOI:
https://doi.org/10.1002/14651858.CD010810.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 07 julio 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Fibrosis quística y enfermedades genéticas

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Lucan Jiang

    Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China

    Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China

    Evidence‐Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China

    West China School of Pharmacy, Sichuan University, Chengdu, China

  • Yi Liu

    Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China

    Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China

    Evidence‐Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China

    West China School of Pharmacy, Sichuan University, Chengdu, China

  • Lingli Zhang

    Correspondencia a: Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China

    [email protected]

    Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China

    Evidence‐Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China

  • Cristina Santoro

    Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Rome, Italy

  • Armando Rodriguez

    Association for the Promotion of Multimedia Education, Zagreb, Croatia

Contributions of authors

 Roles and responsibilities

Task

Who undertook the task?

Protocol stage: draft the protocol

Yi Liu; Cristina Santoro; Armando Rodriguez

Review stage: perform the searches

Yi Liu; Cristina Santoro; Jie Song; Cochrane Cystic Fibrosis and Genetic Disorders Group

Review stage: perform the discussion

Yi Liu; Lingli Zhang; Cristina Santoro

Review stage: perform the conclusion

Yi Liu; Lingli Zhang; Li Wang

Review stage: draft the final review

Yi Liu; Lingli Zhang; Jie Song; Armando Rodriguez

Update stage: update the review

Lucan Jiang; Yi Liu; Lingli Zhang; Cristina Santoro; Armando Rodriguez

Sources of support

Internal sources

  • Sichuan University, China.

    Free Databases

  • West China Second University Hospital,Sichuan University, China.

    Free Database

External sources

  • Natural Science Foundation of China: Evidence based establishment of evaluation index system for pediatric rational drug use in China (No. 81373381), China.

  • National Institute for Health Research, UK.

    This systematic review was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group.

Declarations of interest

All authors: none known.

Acknowledgements

Many thanks to all authors' affiliated institutions and organizations, and thank the Co‐ordinating Editor, referees and Editors of the Cochrane Cystic Fibrosis and Genetic Disorders Group for their comments and encouragement.

This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2020 Aug 03

Rituximab for treating inhibitors in people with inherited severe hemophilia

Review

Lucan Jiang, Yi Liu, Lingli Zhang, Cristina Santoro, Armando Rodriguez

https://doi.org/10.1002/14651858.CD010810.pub4

2017 Jul 07

Rituximab for treating inhibitors in people with inherited severe hemophilia

Review

Lucan Jiang, Yi Liu, Lingli Zhang, Cristina Santoro, Armando Rodriguez

https://doi.org/10.1002/14651858.CD010810.pub3

2015 Apr 04

Rituximab for treating inhibitors in people with inherited severe hemophilia

Review

Yi Liu, Lingli Zhang, Cristina Santoro, Jie Song, Armando Rodriguez, Li Wang

https://doi.org/10.1002/14651858.CD010810.pub2

2013 Oct 30

Rituximab for treating inhibitors in children with hemophilia

Protocol

Yi Liu, Lingli Zhang, Cristina Santoro, Jie Song, Armando Rodriguez, Li Wang

https://doi.org/10.1002/14651858.CD010810

Differences between protocol and review

  • The authors and editorial team agreed to expand the review from including children only, to include people of all ages.

  • The third authors' detail has been changed from "West China Second University Hospital, Sichuan University" to "West China College of Pharmacy, Sichuan University".

  • Because of this empty review, the contributions of authors have changed.

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

Ir a la figura de la revisiónAbrir en una pestaña nueva